September 2016

Altasciences Clinical Research - Algorithme Pharma banner

Industry News

|

Ask the Experts

|

CNS Symposium

 

Industry News

HHS Awards $53 million to Help Address Opioid Epidemic

The U.S. Department of Health and Human Services announced $53 million in funding to "improve access to treatment for opioid use disorders, reduce opioid related deaths, and strengthen drug misuse prevention efforts. In addition, funding will also support improved data collection and analysis around opioid misuse and overdose as well as better tracking of fatal and nonfatal opioid-involved overdoses."

 
See the Announcement

____

Ask the Experts

Do you have a question about your drug development program or a clinical trial? Get access to some of the industry's leading experts here.

Graham Wood, PhD, Executive Vice President, Phase I Clinical Development

NDA filing studies

Graham Wood, PhD, Executive Vice President, Phase I Clinical Development at Altasciences, will be speaking at the 16th Clinical Trials in Canada Summit on October 5th.

Click below to download his latest guide to NDA Filing Studies or ask a question of Dr. Wood.

Brian Falus, Recruitment Marketing Strategist

Recruitment

Brian Falus, Recruitment Marketing Strategist at Altasciences, created the "Secret to On-Time Participant Recruitment and Retention" whitepaper that outlines tools for participant relationship managment, enhancing the web site experience, and the use of online web systems. Click below to see the whitepaper or ask Brian a question about the recruitment and retention of volunteers in clinical trials.

More info
More info

____

CNS Symposium

If you weren't able to attend our symposium in Boston on early phase development of centrally-acting drugs, that's okay. We'd be happy to share the presentation with you. Click below to request the slides now.

PharmaVOICE 100

Did you hear our news? Chris Perkin, CEO at Altasciences, was named one of the 100 Most Inspiring People In Life Sciences. You can read all about it by clicking the link below.

First in Human

An experienced CRO can minimize the risk of recruitment and retention issues, safety concerns, bad data and a whole myriad of other issues that could slow down your FIH clinical trial. Find out what it takes to conduct these unique studies.

Request Presentation
Read the Article
Read the Blog
 

____

Does your drug impact driving ability?

Join Us at an Upcoming Conference!

Barcelona, Spain

CPhI Worldwide — Booth 3G60
Barcelona, Spain
October 4-6

Chicago, Illinois

Pain Therapeutics Summit
Chicago, Illinois
October 19-20

Arlington, Virginia

HAL & ADF Summit
Arlington, Virginia
November 2-3

Denver, Colorado

AAPS — Booth 1315
Denver, Colorado
November 13-17

See all conferences

____

Website

Website

Twitter

Twitter

LinkedIn

LinkedIn

Youtube

Youtube

 

Algorithme Pharma Vince and Associates Algorithme Pharma  USA

 

©2016 All right reserved, Altasciences Inc.